Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome).

Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome). J Am Coll Cardiol. 2014 Mar 25; 63(11):1048-57.

View in: PubMed

subject areas

Acute Coronary Syndrome
Aged
Confidence Intervals
Coronary Artery Bypass
Electrocardiography
Female
Follow-Up Studies
Hospital Mortality
Humans
Kaplan-Meier Estimate
Lactones
Male
Middle Aged
Myocardial Ischemia
Postoperative Complications
Postoperative Hemorrhage
Proportional Hazards Models
Prospective Studies
Pyridines
Receptors, Thrombin
Reference Values
Risk Assessment
Severity of Illness Index
Stroke
Survival Analysis
Treatment Outcome

authors with profiles

Robert Harrington